Newsletter

Subscribe and receive updates on this company

Text STOCKS to 72727 for mobile alerts

We are excited to present Bioadaptives, Inc. (OTC: BDPT).

Full DD Report for BDPT

You must become a subscriber to view this report.


Recent News from (OTC: BDPT)

BioAdaptives (OTCPink:BDPT) Announces Canadian Acquisition
LAS VEGAS, March 22, 2018 (GLOBE NEWSWIRE) -- BioAdaptives, Inc., an OTC public company trading under the ticker symbol BDPT (OTCPink) announced that it has signed a Letter of Intent with1682593 Ontario Limited to acquire the assets of Philco Animal Health Inc. Philco Animal Health is a ...
Source: GlobeNewswire
Date: March, 22 2018 09:00
BioAdaptives (OTC PINK: BDPT) Announces New Management
LAS VEGAS, March 15, 2018 (GLOBE NEWSWIRE) -- BioAdaptives, Inc., a fully-reporting public company trading under the ticker symbol BDPT (OTC PINK:BDPT) announced that Mr. Kim D. Southworth has assumed the position of Chief Executive Officer of the Company upon the resignation of Mr. Christo...
Source: GlobeNewswire
Date: March, 15 2018 06:00
Gawk Inc. Issues State of The Company Letter to Shareholders
LOS ANGELES, CA--(Marketwired - Feb 23, 2016) - GAWK Inc. ( OTC PINK : GAWK ) CEO Scott Kettle reviews the past fiscal year with a letter to all shareholders. Dear Shareholder: The State of your Company is strong! GAWK, Inc. ( OTC PINK : GAWK ) is bottom line profitable and our prospec...
Source: Marketwired
Date: February, 23 2016 08:30
BioAdaptives, Inc. Expands Inventory Bringing Order Fulfillment In-House
LAS VEGAS, NV--(Marketwired - Feb 16, 2016) - BioAdaptives, Inc. ( OTCBB : BDPT ) announced the completion of a transaction to purchase inventory valued at just under $1,100,000 in retail products. The products include PrimiCell®, PrimiLive®, PrimiTrim™, and Equine Regen&#x...
Source: Marketwired
Date: February, 16 2016 10:01
Promoting Financial Growth through Impending Nationwide Product Roll-Out
BioAdaptives, Inc. (OTC: BDPT) is engaged in the research and development of science-based nutraceutical products for human and animal consumption. By sourcing high quality raw materials, the company is able to develop innovative products designed to improve overall health and wellness by pr...
Source: DreamTeamNetwork
Date: August, 25 2015 09:30

 


About Bioadaptives, Inc. (OTC: BDPT)

Logo for Bioadaptives, Inc. (OTC: BDPT)

BioAdaptives Inc. is a research and development company. Our current focus is on products that improve health and wellness. These products include dietary supplements, specialty food items, and proprietary methods of optimizing the bioelectromagnetic availability of foods and beverages. Our base of intellectual property and products include solutions in the form of devices and nutraceuticals that are designed to aid in cognition, focus, fatigue reduction, weight control, improved overall emotional and physical wellness, healing, and anti aging. The original products were designed for and tested on humans and we have now found that many of those original products, when optimized for the species, work as well or better for pets such as horses, dogs, and cats.

 

Contact Information

 

 

Current Management

  • Chris Hall / CEO, President, Interim CFO
  • Barry K Epling / Chairman

Current Share Structure

  • Market Cap: $2,410,678 - 03/12/2018
  • Authorized: 100,000,000 - 12/31/2013
  • Issue and Outstanding: 14,180,456 - 08/18/2016

 


Recent Filings from (OTC: BDPT)

Certification of Termination of Registration
Filing Type: 15-15DFiling Source: edgar
Filing Date: March, 31 2017
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: November, 18 2016
Notification that form 10-Q will be submitted late
Filing Type: NT 10-QFiling Source: edgar
Filing Date: November, 15 2016
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: August, 18 2016
Notification that form 10-Q will be submitted late
Filing Type: NT 10-QFiling Source: edgar
Filing Date: August, 16 2016
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 23 2016
Notification that form 10-Q will be submitted late
Filing Type: NT 10-QFiling Source: edgar
Filing Date: May, 17 2016
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: April, 14 2016
Notification that form 10-K will be submitted late
Filing Type: NT 10-KFiling Source: edgar
Filing Date: March, 31 2016
Filing by person(s) reporting owned shares of common stock in a public company >5%
Filing Type: SC 13DFiling Source: edgar
Filing Date: January, 05 2016

 

 


Daily Technical Chart for (OTC: BDPT)

Daily Technical Chart for (OTC: BDPT)


Stay tuned for daily updates and more on (OTC: BDPT)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: BDPT)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

Monsta Trader
@MonstaTrader

 

 


Disclaimer: Monsta Trader publishes reports providing information on selected companies. Monsta Trader is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. Monsta Trader accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in BDPT is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. Monsta Trader has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. Monsta Trader does not own any shares of BDPT and does not buy, sell, or trade any shares of BDPT. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by Monsta Trader. All rights reserved. Our Full Disclaimer: http://monstatrader.com/disclaimer/